Cargando…

Spontaneous portomesenteric thrombosis in a non-cirrhotic patient with SARS-CoV-2 infection

Intra-abdominal thromboses are a poorly characterised thrombotic complication of COVID-19 and are illustrated in this case. A 42-year-old man with chronic hepatitis B (undetectable viral load, FibroScan 7.4 kPa) developed fever and cough in March 2020. 14 days later, he developed right upper quadran...

Descripción completa

Detalles Bibliográficos
Autores principales: Abeysekera, Kushala WM, Karteszi, Hedvig, Clark, Amanda, Gordon, Fiona H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757448/
https://www.ncbi.nlm.nih.gov/pubmed/33371000
http://dx.doi.org/10.1136/bcr-2020-238906
_version_ 1783626751907201024
author Abeysekera, Kushala WM
Karteszi, Hedvig
Clark, Amanda
Gordon, Fiona H
author_facet Abeysekera, Kushala WM
Karteszi, Hedvig
Clark, Amanda
Gordon, Fiona H
author_sort Abeysekera, Kushala WM
collection PubMed
description Intra-abdominal thromboses are a poorly characterised thrombotic complication of COVID-19 and are illustrated in this case. A 42-year-old man with chronic hepatitis B (undetectable viral load, FibroScan 7.4 kPa) developed fever and cough in March 2020. 14 days later, he developed right upper quadrant pain. After being discharged with reassurance, he re-presented with worsening pain on symptom day 25. Subsequent abdominal ultrasound suggested portal vein thrombosis. CT of the abdomen confirmed portal and mid-superior mesenteric vein thromboses. Concurrent CT of the chest suggested COVID-19 infection. While reverse transcription PCR was negative, subsequent antibody serology was positive. Thrombophilia screen excluded inherited and acquired thrombophilia. Having been commenced on apixaban 5 mg two times per day, he is currently asymptomatic. This is the first case of COVID-19-related portomesenteric thrombosis described in the UK. A recent meta-analysis suggests 9.2% of COVID-19 cases develop abdominal pain. Threshold for performing abdominal imaging must be lower to avoid this reversible complication.
format Online
Article
Text
id pubmed-7757448
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-77574482020-12-28 Spontaneous portomesenteric thrombosis in a non-cirrhotic patient with SARS-CoV-2 infection Abeysekera, Kushala WM Karteszi, Hedvig Clark, Amanda Gordon, Fiona H BMJ Case Rep Case Report Intra-abdominal thromboses are a poorly characterised thrombotic complication of COVID-19 and are illustrated in this case. A 42-year-old man with chronic hepatitis B (undetectable viral load, FibroScan 7.4 kPa) developed fever and cough in March 2020. 14 days later, he developed right upper quadrant pain. After being discharged with reassurance, he re-presented with worsening pain on symptom day 25. Subsequent abdominal ultrasound suggested portal vein thrombosis. CT of the abdomen confirmed portal and mid-superior mesenteric vein thromboses. Concurrent CT of the chest suggested COVID-19 infection. While reverse transcription PCR was negative, subsequent antibody serology was positive. Thrombophilia screen excluded inherited and acquired thrombophilia. Having been commenced on apixaban 5 mg two times per day, he is currently asymptomatic. This is the first case of COVID-19-related portomesenteric thrombosis described in the UK. A recent meta-analysis suggests 9.2% of COVID-19 cases develop abdominal pain. Threshold for performing abdominal imaging must be lower to avoid this reversible complication. BMJ Publishing Group 2020-12-22 /pmc/articles/PMC7757448/ /pubmed/33371000 http://dx.doi.org/10.1136/bcr-2020-238906 Text en © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage
spellingShingle Case Report
Abeysekera, Kushala WM
Karteszi, Hedvig
Clark, Amanda
Gordon, Fiona H
Spontaneous portomesenteric thrombosis in a non-cirrhotic patient with SARS-CoV-2 infection
title Spontaneous portomesenteric thrombosis in a non-cirrhotic patient with SARS-CoV-2 infection
title_full Spontaneous portomesenteric thrombosis in a non-cirrhotic patient with SARS-CoV-2 infection
title_fullStr Spontaneous portomesenteric thrombosis in a non-cirrhotic patient with SARS-CoV-2 infection
title_full_unstemmed Spontaneous portomesenteric thrombosis in a non-cirrhotic patient with SARS-CoV-2 infection
title_short Spontaneous portomesenteric thrombosis in a non-cirrhotic patient with SARS-CoV-2 infection
title_sort spontaneous portomesenteric thrombosis in a non-cirrhotic patient with sars-cov-2 infection
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757448/
https://www.ncbi.nlm.nih.gov/pubmed/33371000
http://dx.doi.org/10.1136/bcr-2020-238906
work_keys_str_mv AT abeysekerakushalawm spontaneousportomesentericthrombosisinanoncirrhoticpatientwithsarscov2infection
AT karteszihedvig spontaneousportomesentericthrombosisinanoncirrhoticpatientwithsarscov2infection
AT clarkamanda spontaneousportomesentericthrombosisinanoncirrhoticpatientwithsarscov2infection
AT gordonfionah spontaneousportomesentericthrombosisinanoncirrhoticpatientwithsarscov2infection